Florbetaben
- 0 on aging of 6 trials, 1 with no results posted
Trials
0 on aging of 6In trials
Phase 3Results posted4 trials
Amyloid plaque
Phase 3Results posted4 trials
Phase 2Results posted1 trial
Trial sponsors
1 trialPhase 1/29 people
1 trialEarly phase 13 people
Latest
27 in 12 monthsmedRxiv
Association of total and brain-derived Alzheimer's disease plasma biomarkers with brain amyloid deposition in a community-based sample
Preprint: cohort study of 541 peopleBiomarkers
AAIC 2025 Abstract
Sleep apnea moderation of cortical amyloid‐β and plasma p ‐tau217 in ethnically diverse older adults
Cohort study of 288 peopleSleep apnea
AAIC 2025 Abstract
Population enrichment strategy using APOE ε4 genotype in tau‐targeting trials for preclinical Alzheimer's disease
Study of 96 peopleAlzheimer's disease
AAIC 2025 Abstract
Imaging‐based Biological Staging for Alzheimer's Disease Prognosis
Cohort study of 662 peopleAlzheimer's disease
AAIC 2025 Abstract
Exploring kidney function thereshole for plasma p ‐tau 217 use
Cohort study of 294 peopleBiomarkers
AAIC 2025 Abstract
Differential Performance of p ‐tau217 in Reflecting Amyloid and Tau Stages in Cognitively Unimpaired and Impaired Individuals
Cohort study of 237 peoplep-Tau217
GSA 2025 Abstract
Machine Learning–Based Motor Reserve Index and Nigral Free Water in Older Adults
Cohort study of 84 peopleBiomarkers